The opioid crisis is still costing lives and devastating communities, but its impact on the labour market is at least beginning to fade. The sharp fall in prescription rates last year suggests that the recent decline in disability – and the related rebound in labour force participation – has further to run.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to gain:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services